On July 31, the Trump administration revealed plans to increase tariffs on Canadian imports by 35%. The rationale behind this move hinges on Canada’s inadequate response to the growing presence of fentanyl traffickers across its territory.
Canada’s reaction has been strongly criticized. Federal officials have communicated with Premier Doug Ford, who has suggested a retaliatory fee.
Some may view this as an exaggerated response from the U.S., but it stems from very real issues. Criminal organizations are indeed exploiting Canada, using it as a significant trafficking route for fentanyl. Recent discoveries in British Columbia have underscored the state’s struggle with this issue, as precursor chemicals flow in from China before entering the domestic market or being rerouted to the U.S.
While the volume of fentanyl crossing the northern border is still small compared to that from the south, it’s noteworthy that fentanyl-related seizures in this region are on the rise, constituting less than 1% of the total U.S. engagement.
Despite the low volume, the potency of the drugs seized is alarming. Estimates suggest that fentanyl coming from Canada could potentially be lethal to around 9 million Americans.
The concern isn’t whether Canada is a major trafficking route, but rather how much its use is increasing. It’s a complex situation.
The problem lies in the structural weaknesses within Canada. Criminal networks have historically taken advantage of regulatory gaps and fragmented enforcement, along with unclear corporate laws.
Canada has gained notoriety for money laundering, particularly related to real estate. Various trade-based money laundering schemes are misused repeatedly, and issues of bribery and corruption have long posed significant risks. Historically, Canada has approached organized crime as a localized public safety challenge instead of recognizing it as a broader threat to national security.
These tariff increases are more than just a headline in a trade war; they reflect a deeper strategy aimed at accountability on a national scale.
The U.S. has also linked Venezuela’s National Embedded Trafficking Network directly to cartel activities, with the Maduro government recently designated a global terrorist organization—a move that occurred just days before the tariffs against Canada were announced.
Similarly, Mexico falls under scrutiny. Back in February, the U.S. imposed a 25% fentanyl-related tariff on Mexican goods due to the government’s ongoing struggles with cartel activity, which is set to rise to 30%.
Mexico managed to negotiate a temporary grace period, pledging more resources to bolster security at its northern border, continuing a framework of escalation against trafficking.
Canada finds itself in a similarly precarious situation. While it’s traditionally a U.S. ally and a partner in the US-Mexico-Canada Agreement, these relationships do not exempt it from facing repercussions.
Historically, Canadian efforts to combat fentanyl have been fragmented and lack resources, but the situation shifted significantly once the 35% tariff was announced.
In a move towards credibility, Ottawa has started to act urgently. The newly introduced Border Security Initiative focuses on enhancing detection infrastructure, forming joint strike teams, and identifying shell entities obscuring financial flows across borders. These initiatives may prove crucial.
Two of Canada’s largest banks were notably central to challenges regarding significant money laundering issues last year.
Royal Bank of Canada’s U.S. subsidiary faced a hefty fine of $65 million, and TD Bank received permission in a U.S. federal court for its involvement in facilitating $650 million in suspected fentanyl-related income.
TD ultimately paid a $3 billion penalty and agreed to be monitored by government-appointed experts. Regulatory authorities have been criticized for underestimating the risks of money laundering, exposing significant systemic gaps that risk being ignored.
This situation transcends partisanship; it highlights structural enforcement related to financial leverage. It’s reshaping America’s approach to the trafficking crisis. Drug routes are increasingly seen not merely as law enforcement issues, but as matters of national sovereignty. The array of responses—whether tariffs, sanctions, or other financial measures—illustrates this shift.
While Canada’s economy itself isn’t the target, the vulnerabilities present certainly are. If left unaddressed, the repercussions could be dire. Trade penalties may multiply, correspondent banks could withdraw, investment flow could dwindle, and trust—across financial, diplomatic, and regulatory institutions—would erode.
The Canadian government has a finite opportunity to strengthen its enforcement reliability. This means addressing money laundering loopholes, cooperating with U.S. institutions, and developing a comprehensive national strategy against cross-border organized crime.
This isn’t merely rhetorical; immediate action is required. Because fentanyl isn’t waiting, nor are human traffickers, and it seems the Trump administration isn’t backing down either.
